{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T07:44:57Z","timestamp":1776930297994,"version":"3.51.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inherited retinal diseases (IRDs) are a leading cause of visual impairment in children and young adults. Individuals with IRDs have an increased prevalence of high refractive errors (REs). This study aims to characterise the natural progression of REs in patients with early onset IRDs and identify associations with specific IRDs and genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study of patients diagnosed with IRD\u2019s up to the age of 10 years. Data collected included demographic information, IRD type, molecular analysis (when available), and cycloplegic REs from the first and last visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 199 patients (384 refractive measurements) were included in this study. Retinitis Pigmentosa (RP) and Achromatopsia were associated with high hypermetropia in early visits, with a decreasing RE trend over time.\n                      <jats:italic>CNGA3, CNGB3<\/jats:italic>\n                      , and\n                      <jats:italic>CRB1<\/jats:italic>\n                      were associated with high hypermetropia, remaining high with time in\n                      <jats:italic>CRB1<\/jats:italic>\n                      . In contrast, Congenital Stationary Night Blindness (CSNB) and Blue Cone Monochromacy (BCM) demonstrated high myopia, worsening over time in CSNB, with an increasing rate in high myopia from 51.5% to 69.7% from first to last visit. Mean myopic progression in\n                      <jats:italic>TRPM1<\/jats:italic>\n                      -patients was 0.56 dioptres\/year.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In patients with early onset IRDs, refractive errors have a general tendency towards lower spherical equivalents with time.\n                      <jats:italic>TRPM1<\/jats:italic>\n                      -related myopia keeps progressing during the first decade of life, warranting regular screening and consideration of early myopia control interventions to mitigate the risk of myopia-related sight-threatening complications. High hypermetropia is common in RP, staying especially high in\n                      <jats:italic>CRB1<\/jats:italic>\n                      -related cases, highlighting the importance of early screening and refractive correction.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-025-03987-9","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:45:27Z","timestamp":1757637927000},"page":"2940-2944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Natural course of refractive errors in early onset inherited retinal diseases"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3132-8953","authenticated-orcid":false,"given":"Rotem","family":"Azmon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Ezra Kahtan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Hendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-3568","authenticated-orcid":false,"given":"Claudia","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"3987_CR1","unstructured":"Rivolta C, Sharon D, DeAngelis MM, Dryja TP. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns [Internet]. Available from: http:\/\/eyegene.meei.harvard.edu"},{"key":"3987_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/13816810.2021.1913610","volume":"42","author":"RC Heath Jeffery","year":"2021","unstructured":"Heath Jeffery RC, Mukhtar SA, McAllister IL, Morgan WH, Mackey DA, Chen FK. Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia. Ophthalmic Genet. 2021;42:431\u20139.","journal-title":"Ophthalmic Genet"},{"key":"3987_CR3","doi-asserted-by":"crossref","unstructured":"Tawfik CA, Roshdy MM, Morris NM. Prevalence of inherited retinal diseases in a large Egyptian cohort. BMC Ophthalmol. 2023;1;23.","DOI":"10.1186\/s12886-023-03163-1"},{"key":"3987_CR4","unstructured":"Naidoo KS, Leasher J, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, et al. Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990Y2010 [Internet]. Available from: www.anglia.ac.uk\/verugbd"},{"key":"3987_CR5","doi-asserted-by":"crossref","unstructured":"Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P. Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: An evidence-based systematic review. Am J Ophthalmol. 2014;157:9\u201325.","DOI":"10.1016\/j.ajo.2013.08.010"},{"key":"3987_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342.","journal-title":"Ophthalmology"},{"key":"3987_CR7","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.ophtha.2013.03.002","volume":"120","author":"MMC Bijveld","year":"2013","unstructured":"Bijveld MMC, Florijn RJ, Bergen AAB, Van Den Born LI, Kamermans M, Prick L, et al. Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. Ophthalmology. 2013;120:2072\u201381.","journal-title":"Ophthalmology"},{"key":"3987_CR8","doi-asserted-by":"crossref","unstructured":"Flaxel CJ, Jay M, Thiselton DL, Nayudu M, Hardcastle AJ, Wright A, et al. DiVerence between RP2 and RP3 phenotypes in X linked retinitis pigmentosa., Br J Ophthalmol. 1999;83:1144\u201348.","DOI":"10.1136\/bjo.83.10.1144"},{"key":"3987_CR9","doi-asserted-by":"crossref","unstructured":"Sadowski B, Zrenner E. Cone and Rod Function in Cone Degenerations, Vision Res. 1997;37:2303\u201314.","DOI":"10.1016\/S0042-6989(97)00025-4"},{"key":"3987_CR10","doi-asserted-by":"crossref","unstructured":"Gregory-Evans K, Kelsell RE, Gregory-Evans CY, Downes SM, Fitzke FW, Holder GE, et al. Autosomal Dominant Cone-Rod Retinal Dystrophy (CORD6) from Heterozygous Mutation of GUCY2D, which Encodes Retinal Guanylate Cyclase. 2000.","DOI":"10.1016\/S0161-6420(99)00038-X"},{"key":"3987_CR11","unstructured":"Wagner RS, Caputo AR, Nelson LB, Zanoni D. High Hyperopia in Leber\u2019s Congenital Amaurosis."},{"key":"3987_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ajo.2017.07.008","volume":"182","author":"M Hendriks","year":"2017","unstructured":"Hendriks M, Verhoeven VJM, Buitendijk GHS, Polling JR, Meester-Smoor MA, Hofman A, et al. Development of Refractive Errors\u2014What Can We Learn From Inherited Retinal Dystrophies? Am J Ophthalmol. 2017;182:81\u20139.","journal-title":"Am J Ophthalmol"},{"key":"3987_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ajo.2024.09.011","volume":"269","author":"SH Yassin","year":"2025","unstructured":"Yassin SH, Wagner NE, Khuu T, Schmidt R, Igelman AD, Marra M, et al. Refractive Error in Inherited Retinal Disease. Am J Ophthalmol. 2025;269:381\u201392.","journal-title":"Am J Ophthalmol"},{"key":"3987_CR14","first-page":"169","volume":"28","author":"DI Flitcroft","year":"2014","unstructured":"Flitcroft DI. Emmetropisation and the aetiology of refractive errors. Eye (Basingstoke). 2014;28:169\u201379.","journal-title":"Eye (Basingstoke)"},{"key":"3987_CR15","doi-asserted-by":"crossref","unstructured":"Igelman AD, White E, Tayyib A, Everett L, Vincent A, Heon E, et al. Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study. Br J Ophthalmol. 2025;109:286\u201392.","DOI":"10.1136\/bjo-2023-323747"},{"key":"3987_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/iovs.65.14.9","volume":"65","author":"MMF Poels","year":"2024","unstructured":"Poels MMF, de Wit GC, Bijveld MMC, van Genderen MM. Natural Course of Refractive Error in Congenital Stationary Night Blindness: Implications for Myopia Treatment. Invest Ophthalmol Vis Sci. 2024;65:9.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3987_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46811-7","volume":"9","author":"A AlTalbishi","year":"2019","unstructured":"AlTalbishi A, Zelinger L, Zeitz C, Hendler K, Namburi P, Audo I, et al. TRPM1 Mutations are the Most Common Cause of Autosomal Recessive Congenital Stationary Night Blindness (CSNB) in the Palestinian and Israeli Populations. Sci Rep. 2019;9:12047.","journal-title":"Sci Rep"},{"key":"3987_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.9.13.13","volume":"9","author":"EP Semenov","year":"2020","unstructured":"Semenov EP, Sheplock R, Roman AJ, McGuigan DB, Swider M, Cideciyan AV, et al. Reading performance in blue cone monochromacy: Defining an outcome measure for a clinical trial. Transl Vis Sci Technol. 2020;9:1\u201316.","journal-title":"Transl Vis Sci Technol"},{"key":"3987_CR19","doi-asserted-by":"crossref","unstructured":"Mathijssen IB, Florijn RJ, Ingeborgh Van Den Born L, Zekveld-Vroon RC, Ten Brink JB, Plomp AS, et al. Long-Term Follow-Up Of Patients With Retinitis Pigmentosa Type 12 Caused By Crb1 Mutations A Severe Phenotype With Considerable Interindividual Variability [Internet]., RETINA. 2017;37 Available from: http:\/\/journals.lww.com\/retinajournal","DOI":"10.1097\/IAE.0000000000001127"},{"key":"3987_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajo.2020.10.006","volume":"223","author":"Y Wang","year":"2021","unstructured":"Wang Y, Sun W, Xiao X, Li S, Jia X, Wang P, et al. Clinical and Genetic Analysis of 63 Families Demonstrating Early and Advanced Characteristic Fundus as the Signature of CRB1 Mutations. Am J Ophthalmol. 2021;223:160\u20138.","journal-title":"Am J Ophthalmol"},{"key":"3987_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ajo.2022.09.002","volume":"246","author":"M Daich Varela","year":"2023","unstructured":"Daich Varela M, Georgiou M, Alswaiti Y, Kabbani J, Fujinami K, Fujinami-Yokokawa Y, et al. CRB1-Associated Retinal Dystrophies: Genetics, Clinical Characteristics, and Natural History. Am J Ophthalmol. 2023;246:107\u201321.","journal-title":"Am J Ophthalmol"},{"key":"3987_CR22","doi-asserted-by":"crossref","unstructured":"Andersen MKG, Bertelsen M, Gr\u00f8nskov K, Kohl S, Kessel L. Genetic and Clinical Characterization of Danish Achromatopsia Patients. Genes (Basel). 2023;1:14.","DOI":"10.3390\/genes14030690"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03987-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03987-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03987-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:05:27Z","timestamp":1762171527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03987-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":22,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3987"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03987-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}